As clinical trials become increasingly complex, the weight on clinical research sites and patients continues to grow, making collectively beneficial clinical trial agreements and site budget negotiations imperative.

Inadequate site budget negotiations can contribute to trial timeline delays, poor patient enrollment, and financial instability for sites and sponsors, and can often lead to mistrust between all parties involved. If not handled efficiently, delays in the process can negatively impact an entire study.

Download the white paper to review findings from research into how to navigate the complex site negotiation process, identify coping strategies, combat budget negotiation challenges, and achieve mutually beneficial agreements.